Vemurafenib and salts thereof for use in the treatment of enteroviral infections
AssigneeJyväSkyläN Yliopisto
InventorsVarpu Marjomäki, Mira Laajala, Mari Martikainen
Life of this patent
Estimating the term…
Abstract
The present invention provides N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide known as vemurafenib, and pharmaceutical salts thereof for use in the treatment of enteroviral diseases.
Claims14
A method for treating, alleviating, or reducing an enteroviral infection caused by an enterovirus comprising administering a pharmaceutical product comprising vemurafenib or a pharmaceutically acceptable salt thereof to a subject suffering from said enteroviral infection, wherein the enterovirus is selected from the group consisting of coxsackieviruses B and polioviruses.
Dependencies are inferred from the claim text.